The link between FOXJ1 expression level in bladder carcinoma and tumor recurrence

Area of Science:

• Oncology
• Molecular Biology
• Urology

Background:

• Bladder epithelial carcinoma is a significant health concern.
• The role of specific gene expression, such as FOXJ1, in bladder cancer progression requires further elucidation.

Purpose of the Study:

• To investigate the expression levels of FOXJ1 in bladder epithelial carcinoma.
• To analyze the correlation between FOXJ1 expression and clinical features, including tumor staging, recurrence, and patient survival.

Main Methods:

• Utilized immunohistochemical staining to assess FOXJ1 protein expression.
• Employed RT-PCR to measure FOXJ1 mRNA levels in tumor and para-carcinoma tissues from 66 patients.
• Correlated molecular findings with clinical data.

Main Results:

• FOXJ1 expression was significantly lower in bladder tumor tissues compared to para-carcinoma tissues.
• Lower FOXJ1 expression correlated with advanced neoplasm staging and higher tumor recurrence rates.
• Patients with positive FOXJ1 expression exhibited significantly longer median survival times.

Conclusions:

• FOXJ1 is underexpressed in bladder epithelial carcinoma and is associated with aggressive tumor characteristics.
• FOXJ1 may serve as a potential biomarker for early diagnosis and predicting recurrence in bladder cancer.
• Further research into FOXJ1's biological mechanisms in bladder cancer development is warranted.